246710 fundamentals
Key facts
T&R Biofab Co., Ltd engages in the manufacture and sale of biomedical equipment. It operates through the following business divisions: Biodegradable artificial support, 3D Bioprinting System, Bio ink, 3D Organoids, Cell therapy, and ECM-based biosurgical solution. The Biodegradable artificial support division makes scaffolds used reconstructing tissues and organs. The 3D Bioprinting System division deals with technology used in the production of 3D structures. The Bio ink division focuses on ink used in cell printing. The 3D Organoids division provides mini organs. The Cell therapy division treats patients using stem cells. The ECM-based biosurgical solution division focuses on wound treatments. The company was founded on March 11, 2013 and is headquartered in Siheung, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company